Related Experiment Video
Updated: Sep 21, 2025

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
[What's new in pericardial disease?]
Dimitar Divchev1, Mareike Schnurbus1, Bernhard Schieffer1
1Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Phillips-Universität Marburg, Universitätsklinik Gießen und Marburg, Campus Marburg.
Pericardial disease involves inflammation of the pericardium, with causes including SARS-CoV-2 infection. Emerging treatments target auto-inflammation and inflammasomes beyond current anti-inflammatory drugs.
Area of Science:
- Cardiology
- Immunology
Background:
- Pericardial disease encompasses diverse inflammatory injuries to the pericardium.
- Causes are multifactorial, leading to conditions like acute/recurrent pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis.
Purpose of the Study:
- To review current understanding of pericardial diseases.
- To highlight emerging inflammatory pathways and therapeutic targets.
Main Methods:
- Literature review of pericardial disease.
- Analysis of inflammatory mechanisms and treatment strategies.
Main Results:
- Inflammatory pericardial pathologies are currently observed with SARS-CoV-2 infection and post-vaccination.
- Established treatments include NSAIDs, corticosteroids, and colchicine.
Conclusions:
- Auto-inflammation and inflammasomes represent promising targets for advanced pericardial disease treatments.
- Novel therapeutic strategies may offer more specific options beyond current anti-inflammatory approaches.
More Related Videos
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

